Mesa Laboratories, Inc. (MLAB)

NasdaqGS · Scientific & Technical Instruments

122.48
-5.26 (-4.12%)
Updated Oct 17, 6:09 AM ET
AI Rating
Hold
Overall Score
60
Trend
80
Momentum
46
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 1, 2025 260 sessions Oct 13, 2026

AI Analysis

Mesa Laboratories, Inc. is trading at $122.48, down 4.12% on the session. The 50 day average sits at $123.39 and the 200 day at $101.26, which puts the stock in a uptrend. RSI is at 48.9, which reads as neutral, and MACD is bearish crossover. Volume is average.

The nearest support is around $125.13 with resistance near $132.70, so that band frames the current range. Average daily movement is roughly $4.97, or about 4.1% of the share price, which is what any stop placement has to allow for. The overall health score of 60 out of 100 combines a trend score of 80, momentum of 46 and a risk score of 46.

Technical indicators

RSI (14)
48.9
neutral
MACD
1.457
bearish crossover
SMA 20
131.16
SMA 50
123.39
SMA 200
101.26
uptrend
ATR (14)
4.97
avg daily range
Support
125.13
Resistance
132.70
Volume vs 20d
0.90x
average
Volatility
45.5%
annualised
1 month
+5.01%
3 months
+34.73%

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.